Serán BioScience plans commercial facility in Bend, Oregon

Serán BioScience announced a $200 million strategic growth transaction led by Bain Capital Life Sciences to build a new commercial-scale manufacturing facility in Bend, Oregon, expected to be completed in 2027.

“The partnership will support Serán’s continued growth with the build out of a new commercial-scale manufacturing facility that will enable the company to provide integrated capabilities across multiple drug delivery and final dose formats.”seranbio.com

• 1 source
• seranbio.comSerán BioScience Announces Plans for Commercial FacilitySep 17, 2024

Summarized from public sources; check the original articles before acting on it.